Picture EBD Group Biotech Showcase 2025 San Francisco BTS25 650x100px

Organisation › Details

Astellas (Group)

https://www.astellas.com

	Start	2005-04-01 merged
	Industry	pharmaceutical

	Region	Tokyo
	Country	Japan
	Street	2-3-11 Nihonbashi-Honcho, Chuo-ku
	City	103-8411 Tokyo
		Address record changed: 2020-12-02

Basic data	Employees	H: 10,001 to 50,00 (2019-03-31)
	Currency	JPY
	Annual sales	1,306,348,000,000 (revenue, consolidated (2018/19) 2019-03-31)
	Profit	222,265,000,000 (2019-03-31)
	Cash	311,074,000,000 (2019-03-31)


		Record changed: 2024-08-24

Picture Berlin Partner Top News CareSyntax Raises $180m Funding 650x200px

More documents for Astellas (Group)

[1] Mogrify Ltd.. (10/2/23). "Press Release: Mogrify Extends Series A Financing to $46 Million USD". Cambridge....
[2] Novartis AG. (1/24/23). "Press Release: Sandoz Announces Agreement to Acquire Leading Antifungal Agent Mycamine from Astellas, Reinforcing Hospital Offering and Leading Anti-infectives Portfolio". Basel....
[3] Mogrify Ltd.. (7/5/22). "Press Release: Mogrify and Astellas Announce Collaboration to Conduct Research on in vivo Regenerative Medicine Approaches to Address Sensorineural Hearing Loss". Cambridge & Tokyo....
[4] T-Knife Therapeutics, Inc.. (7/12/21). "Press Release: T-Knife Therapeutics Announces the Appointment of Megan Baierlein as Chief Operating Officer". San Francisco, CA & Berlin....
[5] T-Knife GmbH. (1/19/21). "Press Release: T-Knife Announces Appointment of Thomas M. Soloway as Chief Executive Officer and Camille A. Landis as Chief Business Officer & Chief Financial Officer". San Francisco, CA & Berlin....
[6] Amolyt Pharma SAS. (6/8/20). "Press Release: Amolyt Pharma Appoints Pierre Legault as a Director and Chairman of its Board of Directors as Company Transitions into Clinical Stage". Lyon & Newton, MA....
[7] Nanna Therapeutics Ltd.. (4/21/20). "Press Release: Astellas Announces Acquisition of Nanna". Tokyo & Cambridge....
[8] Adaptimmune Therapeutics plc. (1/14/20). "Press Release: Astellas and Adaptimmune Enter into Agreement to Co-Develop and Co-Commercialize Stem-Cell Derived Allogeneic CAR-T and TCR T-Cell Therapies". Tokyo, Philadelphia, PA & Oxfordshire....
[9] Audentes Therapeutics, Inc.. (12/2/19). "Press Release: Astellas Enters into Definitive Agreement to Acquire Audentes Therapeutics". Tokyo & San Francisco, CA....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]